美股
Lead report
Healthcare Weekly: GSK, Parabilis Medicines, and Novo Nordisk in Focus
A deep dive into three key developments in the US healthcare sector this week: GSK's RSV vaccine progress, Parabilis Medicines' rare disease breakthrough, and Novo Nordisk's GLP-1 competition and capacity expansion, offering investment insights.
